Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Niacin safely controls lipid disorders in diabetic patients

Sep. 20, 2000

Researchers identify new nuclear receptor targets for cholesterol control

Sep. 20, 2000

Newly issued patent covers series of guanylate cyclase activators designed by Aventis

Sep. 19, 2000

Guanidine-based Na+/H+ inhibitors synthesized and tested at Sumitomo

Sep. 19, 2000

Banyu's J-112287: a potent, selective and orally active ETA receptor antagonist

Sep. 19, 2000

Complement inhibitor TP-10 to enter phase IIb studies in infants

Sep. 18, 2000

Vasodilating and antiplatelet series designed at Lacer

Sep. 18, 2000

Cardioprotective agents from Pierre Fabre evaluated in several animal models

Sep. 18, 2000

Combination of doxazosin and amlodipine provides increased efficacy, improved tolerability

Sep. 18, 2000

Researchers identify ACE2, the first human homologue of ACE

Sep. 15, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...